PART I Item 1. Bu siness. Overview ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients lives by O vercoming R esistance I n C ancer . Profound advancements in oncology drug development have expanded the treatment options available to patients, yet therapeutic resistance and relapse continue to limit the efficacy and duration of clinical benefit of such treatments. Collectively, our founders and management team have a decades-long heritage of identif...
Q2 FY2026 — expected 2026-08-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-23 | 2025-12-31 | 0001193125-26-064005 | EDGAR | 99K words |
| 2025-02-18 | 2024-12-31 | 0000950170-25-022273 | EDGAR | — |
| 2024-03-11 | 2023-12-31 | 0000950170-24-029298 | EDGAR | — |
| 2023-03-16 | 2022-12-31 | 0000950170-23-008483 | EDGAR | — |
| 2022-03-21 | 2021-12-31 | 0000950170-22-004239 | EDGAR | — |
| 2021-03-23 | 2020-12-31 | 0001564590-21-014865 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-03 | 2026-06-30 | 0001193125-26-330631 | EDGAR | — |
| 2025-11-13 | 2025-09-30 | 0001193125-25-280234 | EDGAR | 66K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107359 | EDGAR | — |
| 2025-05-05 | 2025-03-31 | 0000950170-25-063564 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125471 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095467 | EDGAR | — |
| 2024-05-06 | 2024-03-31 | 0000950170-24-053582 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0000950170-23-059415 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041362 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0000950170-23-018839 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022631 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016894 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-03 | 0001193125-26-330568 | EDGAR | — |
| 2026-07-30 | 0001193125-26-326309 | EDGAR | — |
| 2026-03-31 | 0001193125-26-134618 | EDGAR | 7K words |
| 2026-02-23 | 0001193125-26-064291 | EDGAR | — |
| 2026-02-23 | 0001193125-26-063974 | EDGAR | — |
| 2025-12-08 | 0001193125-25-310472 | EDGAR | — |
| 2025-11-13 | 0001193125-25-280247 | EDGAR | — |
| 2025-11-13 | 0001193125-25-280196 | EDGAR | — |
| 2025-08-12 | 0000950170-25-107313 | EDGAR | — |
| 2025-06-13 | 0001193125-25-140725 | EDGAR | — |
102 total filings indexed. 74 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001796280 |
| Ticker | ORIC |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.oricpharma.com |
| Listed | 2020-04-24 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ORIC (~200 tokens, structured JSON with cryptographic provenance)